Joshua C. Farris

510 total citations
21 papers, 325 citations indexed

About

Joshua C. Farris is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Joshua C. Farris has authored 21 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Radiation. Recurrent topics in Joshua C. Farris's work include Advanced Radiotherapy Techniques (6 papers), Head and Neck Cancer Studies (4 papers) and Cancer-related molecular mechanisms research (4 papers). Joshua C. Farris is often cited by papers focused on Advanced Radiotherapy Techniques (6 papers), Head and Neck Cancer Studies (4 papers) and Cancer-related molecular mechanisms research (4 papers). Joshua C. Farris collaborates with scholars based in United States, Australia and Canada. Joshua C. Farris's co-authors include Steven M. Frisch, James Denvir, Benjamin Cieply, Heide L. Ford, Phillip M. Pifer, Liang Zheng, Eyal Gottlieb, Peter Stoilov, David M. Smith and Ryan T. Hughes and has published in prestigious journals such as Cancer Research, Oncogene and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Joshua C. Farris

17 papers receiving 325 citations

Peers

Countries citing papers authored by Joshua C. Farris

Since Specialization

Citations

This map shows the geographic impact of Joshua C. Farris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua C. Farris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua C. Farris more than expected).

Fields of papers citing papers by Joshua C. Farris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua C. Farris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua C. Farris. The network helps show where Joshua C. Farris may publish in the future.

Co-authorship network of co-authors of Joshua C. Farris

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua C. Farris. A scholar is included among the top collaborators of Joshua C. Farris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua C. Farris. Joshua C. Farris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Grainyhead-like-2, an epithelial master programmer, promotes interferon induction and suppresses breast cancer recurrence 2024 ·Molecular Immunology ·(unknown), Joshua C. Farris, Phillip M. Pifer, Naira V. Margaryan, (unknown), Lei Wang, (unknown), James Denvir, Gangqing Hu, Steven M. Frisch	0
2	The Impact of Prophylactic Bisphosphonates on Radiation-Induced Rib Fractures and Chest Wall Pain in Peripheral Lung Tumor SBRT: A Randomized, Double-Blind, Placebo-Controlled Study 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Michael Farris, Ryan T. Hughes, (unknown), Beverly J. Levine, (unknown), N. Razavian, (unknown), Janardhana Ponnatapura, Joshua C. Farris, (unknown), Kathryn E. Weaver, Glenn J. Lesser, Seung Ho Park, J. Ruiz, J.H. Heinzerling, Jeffrey S. Willey	1
3	Bridging the Communication Gaps: A Prospective Single-Arm Pilot Study Testing the Feasibility of Interdisciplinary Radiotherapy Planning in Locally Advanced Lung Cancer 2023 ·Academic Radiology ·Michael Farris, N. Razavian, Ryan T. Hughes, (unknown), Anna C. Snavely, C.M. Leyrer, (unknown), (unknown), (unknown), Kathryn E. Weaver, Paul M. Bunch, Michael D. Chan, Hollins Clark, (unknown), Joshua C. Farris, (unknown), Stacy Wentworth, Beverly J. Levine, Chandylen L. Nightingale, Janardhana Ponnatapura	3
4	Palliative Appropriateness Criteria: A Pragmatic Method to Evaluate the Suitability of Palliative Radiotherapy Fractionation 2022 ·Journal of Palliative Medicine ·Joshua C. Farris, (unknown), Patrick P. Carriere, (unknown), (unknown), Michael Farris, Ryan T. Hughes	4
5	Intensity‐modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structures 2022 ·Head & Neck ·Joshua C. Farris, (unknown), Paul Black, Michael D. Chan, (unknown), Christina K. Cramer, J. Dale Browne, Joshua D. Waltonen, Christopher A. Sullivan, (unknown), Adrian W. Laxton, Stephen B. Tatter, Bart Frizzell, Mercedes Porosnicu, Thomas Lycan, Kathryn M. Greven, Ryan T. Hughes	5
6	Head and neck radiotherapy quality assurance conference for dedicated review of delineated targets and organs at risk: results of a prospective study 2022 ·Journal of Radiotherapy in Practice ·Joshua C. Farris, N. Razavian, Michael Farris, (unknown), Bart Frizzell, C.M. Leyrer, (unknown), (unknown), Ryan T. Hughes	10
7	Brain Metastasis Incidence and Patterns of Presentation After Definitive Treatment of Locally Advanced Non-Small Cell Lung Cancer: A Potential Argument for Brain Magnetic Resonance Imaging Surveillance 2022 ·Advances in Radiation Oncology ·Joshua C. Farris, Ryan T. Hughes, N. Razavian, (unknown), Anna C. Snavely, Michael D. Chan, (unknown), (unknown), Paul M. Bunch, Jeffrey S. Willey, (unknown)	4
8	Discordance Between Oncology Clinician–Perceived and Radiologist-Intended Meaning of the Postradiotherapy Positron Emission Tomography/Computed Tomography Freeform Report for Head and Neck Cancer 2022 ·JAMA Otolaryngology–Head & Neck Surgery ·(unknown), (unknown), Paul M. Bunch, (unknown), (unknown), (unknown), Joshua C. Farris, Ryan T. Hughes	4
9	Perineural Invasion As the Sole Pathologic Risk Factor After Surgical Resection for Head and Neck Squamous Cell Carcinoma 2021 ·Cureus ·Ryan T. Hughes, Joshua C. Farris, (unknown), Bart Frizzell, Kathryn M. Greven	1
10	Patient assessment of lower urinary tract symptoms using the international prostate symptom score following low-dose-rate prostate brachytherapy 2021 ·Brachytherapy ·Joshua C. Farris, Ryan T. Hughes, (unknown), (unknown), Bart Frizzell	1
11	Patient Reported Outcomes of Urinary Toxicity after Low-Dose-Rate (LDR) Prostate Brachytherapy: Impact of Urethral Dose on Urinary function 2020 ·International Journal of Radiation OncologyBiologyPhysics ·Joshua C. Farris, (unknown), Bart Frizzell	0
12	Five- Versus Ten-Fraction Regimens of Stereotactic Body Radiation Therapy for Primary and Metastatic NSCLC 2020 ·Clinical Lung Cancer ·(unknown), Ryan T. Hughes, M. Soike, (unknown), (unknown), Joshua C. Farris, Michael Farris	7
13	Malignant Pericardial Mesothelioma Treated Using Volumetric Modulated Arc Therapy With a Simultaneous Integrated Boost 2020 ·Advances in Radiation Oncology ·(unknown), Joshua C. Farris, Ryan T. Hughes, (unknown), (unknown), (unknown), (unknown), Michael Farris	0
14	Uncommon Paraneoplastic Complication of Secretory Diarrhea in a Patient with Metastatic Lung Adenocarcinoma 2019 ·(unknown), (unknown), Joshua C. Farris, (unknown)	0
15	Patterns of Relapse After Salvage Autologous Stem Cell Transplant for Hodgkin's Lymphoma: Should Sites of Relapse Relative to Initially Involved Sites Be Used to Guide Indications for Peri-Transplant Radiation Therapy 2018 ·Practical Radiation Oncology ·Joshua C. Farris, (unknown), Michael Craig, Nilay Shah, (unknown), Abraham S. Kanate, Kelly Ross, John A. Vargo	1
16	Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers 2018 ·Molecular Immunology ·(unknown), (unknown), Luke A. Selth, Ian Leighton, Ilya G. Serebriiskii, (unknown), (unknown), Joshua C. Farris, Phillip M. Pifer, Jennifer K. Richer, Steven M. Frisch	22
17	Roles of Grainyhead-like transcription factors in cancer 2017 ·Oncogene ·Steven M. Frisch, Joshua C. Farris, Phillip M. Pifer	50
18	Grainyhead-like 2 Reverses the Metabolic Changes Induced by the Oncogenic Epithelial–Mesenchymal Transition: Effects on Anoikis 2016 ·Molecular Cancer Research ·Joshua C. Farris, Phillip M. Pifer, Liang Zheng, Eyal Gottlieb, James Denvir, Steven M. Frisch	30
19	Epithelial–Mesenchymal Transition and Tumor Suppression Are Controlled by a Reciprocal Feedback Loop between ZEB1 and Grainyhead-like-2 2013 ·Cancer Research ·Benjamin Cieply, Joshua C. Farris, James Denvir, Heide L. Ford, Steven M. Frisch	151
20	Abstract A15: A reciprocal feedback loop between grainyhead-like-2 and ZEB1 controls EMT and tumor suppression 2013 ·Cancer Research ·Benjamin Cieply, Heide L. Ford, Joshua C. Farris, Steven M. Frisch	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact